Body Composition Analyzers Market Report

Global Body Composition Analyzers Market Size

The global body composition analyzers market size was valued at USD 886.15 million in 2025. The body composition analyzers market is predicted to be worth USD 2711.20 million by 2034 and USD 1003.39 million by 2026, growing at a CAGR of 13.23% during the forecast period.

Body composition is the proportion of fat and fat-free mass present in the body. It describes fat, bone, water, and muscle percentages in human bodies. Body Composition Analyzers (BCAs) are used to measure body composition. Healthy body composition refers to one that includes a lower proportion of body fat and a higher ratio of fat-free or lean mass. Since muscular tissue takes up a lesser space in the body than fat tissue, leanness is determined by body weight and body composition. Body Composition Analyzers (BCAs) assess body composition and evaluate the risk of individuals developing diseases like truncal and abdominal obesity.

MARKET DRIVERS

The growing consciousness among people toward health and fitness is propelling the global body composition analyzer market growth. The market for body composition analyzers is further anticipated to be driven by the rising incidence of obesity, overweight, aging population globally, and growing funding from the government and global healthcare institutions for preventive healthcare practices. According to the World Health Organization (WHO), an estimated 1.9 billion people over 18 years were overweight. Furthermore, as mentioned by the Centers for Disease Control and Prevention (CDC), between 2017 and 2018, 42.4% of U.S. adults were obese, according to the National Health and Nutrition Examination Survey. In addition, growing health and fitness consciousness, metabolic disorders, and heart disease are also likely to boost the market demand. Furthermore, the development of the body composition analyzer market is also fuelled by a rise in government programs for a healthier lifestyle, other healthcare organizations, and the World Health Organization (WHO). Furthermore, the rising obese populace, the increasing utility of these analyzers in the sports and fitness industry, and the growing government initiatives to encourage fitness consciousness and physical activity are expected to drive market growth.

Body composition analyzers also aid in measuring various substances found in the body and provide precise values during the examination. In addition, some analyzers can detect accumulated changes in body structure over a given period. Due to this, the market for body composition analyzers is expected to expand in response to rising health club memberships and increased health consciousness among the public. During the forecast period, developing economies like India and China are expected to offer attractive growth opportunities to key market players.

MARKET RESTRAINTS

High costs associated with the equipment and the inaccuracy of various analyzers hamper the growth of the body composition analyzer market. Furthermore, accurate body composition analyzers determine a person's probability of contracting a particular condition, such as obesity. Furthermore, skinfold tests can be used in cohort trials with obesity-related diseases, another restraining factor to the market.

REPORT COVERAGE

SEGMENTAL ANALYSIS

By Product Insights

The bio-impedance segment of the global body composition analyzers market is expected to hold the largest share during the forecast period. The advantages of bio-impedance analyzers over other body composition analyzers, such as ease of use, low cost, and higher precision, can be due to their vast market share.

By End-User Insights

The increase in the number of fitness clubs and health centers worldwide stimulates the sale of body composition analyzers, propelling the market further. The fitness and wellness centers accounted for a significant share of the market in 2024.

On the other hand, the hospital segment is anticipated to register a lucrative CAGR during the forecast period as hospitals are purchasing body structure analyzers to treat various diseases. In addition, the growing trend of living a healthier lifestyle, combined with the advent of smaller, more portable, and easier body composition analyzers, has increased demand for these devices worldwide, particularly in developing countries.

REGIONAL ANALYSIS

In 2023, the North American market led the market owing to deeper technology integration and market access. Increasing demand for health monitoring devices is propelling North America's market growth. When the number of sports injuries rises, so does the need for body structure analyzers in diagnostics, rehabilitation, and therapy centers to monitor athletes' fitness and help their recovery. Among various countries in North America, the U.S. led the market and is anticipated to showcase notable growth during the forecast period.

Europe had a substantial global market share in 2025. During the forecast period, the regional market is anticipated to grow at a healthy CAGR. The growing patient counts suffering from obesity and increasing efforts by EU governments to decrease the incidence of overweight among people are anticipated to propel the regional market growth during the forecast period. In the recent past, the governments of European nations have initiated various programs to promote awareness around health difficulties associated with obesity and the significance of adopting healthy lifestyles. YOY growth in the number of people diagnosed with various metabolic diseases across the European region is fuelling the adoption of body composition analyzers in this region and resulting in regional market growth. On the other hand, high costs and accuracy issues associated with the devices limit the market’s growth rate in this region.

However, the Asia-Pacific is expected to expand at the highest CAGR during the forecast period because of the increasing health and fitness awareness among a vast population base and rising disposable incomes. Healthcare facilities produced the most revenue for body composition analyzers in the APAC industry, led by weight loss and therapy facilities. In addition, the increasing prevalence of fast food associated with the rising disposable income and rapid economic growth, resulting in unhealthy lifestyles, also drives the demand for the body composition analyzer market in this region.

Latin America is predicted to showcase a steady CAGR in the coming years.

The MEA market is forecasted to witness a moderate CAGR during the forecast period. The growing population, increasing investments from developed countries to promote the healthcare infrastructure, and increasing awareness among people regarding the diseases associated with obesity are driving the adoption of the body composition analyzer market in the countries of MEA.

KEY MARKET PLAYERS

Some of the companies that are playing a dominating role in the global body composition analyzers market include

• InBody Co., Ltd (South Korea)
• Tanita Corporation (Japan)
• Omron Corporation (Japan)
• Hologic, Inc. (U.S.)
• GE Healthcare.

MARKET SEGMENTATION

This research report on the global body composition analyzers market has been segmented and sub-segmented based on product, end-user and region.

By Product

• Bio-Impedance Analyser
• Dual Energy X-ray absorptiometry (DEXA)
• Skinfold Callipers
• Air Displacement Plethysmography (ADP)
• Hydrostatic Weighing

By End User

• Hospitals
• Fitness & Wellness Centres
• Academic & Research Centres
• Home-users

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa